- Home
- SNTI vs MOGU Comparison
SNTI vs MOGU Comparison
Compare SNTI & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- MOGU
- Stock Information
- Founded
- SNTI 2016
- MOGU 2011
- Country
- SNTI United States
- MOGU China
- Employees
- SNTI N/A
- MOGU N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- MOGU Business Services
- Sector
- SNTI Health Care
- MOGU Consumer Discretionary
- Exchange
- SNTI Nasdaq
- MOGU Nasdaq
- Market Cap
- SNTI 14.1M
- MOGU 16.2M
- IPO Year
- SNTI N/A
- MOGU 2018
- Fundamental
- Price
- SNTI $2.21
- MOGU $2.17
- Analyst Decision
- SNTI
- MOGU
- Analyst Count
- SNTI 0
- MOGU 0
- Target Price
- SNTI N/A
- MOGU N/A
- AVG Volume (30 Days)
- SNTI 20.4K
- MOGU 8.3K
- Earning Date
- SNTI 11-11-2024
- MOGU 07-09-2024
- Dividend Yield
- SNTI N/A
- MOGU N/A
- EPS Growth
- SNTI N/A
- MOGU N/A
- EPS
- SNTI N/A
- MOGU N/A
- Revenue
- SNTI $338,000.00
- MOGU $22,206,772.00
- Revenue This Year
- SNTI $254.47
- MOGU N/A
- Revenue Next Year
- SNTI $169.66
- MOGU N/A
- P/E Ratio
- SNTI N/A
- MOGU N/A
- Revenue Growth
- SNTI N/A
- MOGU N/A
- 52 Week Low
- SNTI $1.52
- MOGU $1.62
- 52 Week High
- SNTI $8.48
- MOGU $3.58
- Technical
- Relative Strength Index (RSI)
- SNTI 38.51
- MOGU 48.13
- Support Level
- SNTI $2.05
- MOGU $2.26
- Resistance Level
- SNTI $2.48
- MOGU $2.50
- Average True Range (ATR)
- SNTI 0.25
- MOGU 0.25
- MACD
- SNTI -0.05
- MOGU 0.00
- Stochastic Oscillator
- SNTI 12.90
- MOGU 18.03
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.